Apr 11, 2023 7:00am EDT Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
Feb 23, 2023 7:00am EST Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
Feb 22, 2023 7:00am EST Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
Jan 09, 2023 7:00am EST Immunocore announces strategic priorities including pipeline expansion for 2023 -2024